Click here to find more information about the event.
News
Mission
The organisation’s non-profit purpose is to encourage and develop the study and treatment of multiple sclerosis, by means of the various scientific-research disciplines available, in particular clinical research, biology, biochemistry, electrophysiology, immunology, virology, genetics, epidemiology and anatomopathology. To achieve this objective, a close cooperation has been established with the Belgian Charcot Foundation, which was founded within the Belgian Study Group for Multiple Sclerosis to collect funds for research.
The Board
Chairman: Prof Bénédicte Dubois
Vice-president: Prof Guy Laureys
Secretary: Prof Dominique Dive
Members: Dr Melissa Cambron, Dr Brigitte Capron, Dr Bernard Dachy, Dr Miguel D’Haeseleer, Piet Eelen, Prof Souraya El Sankari, Dr Frederic London, Prof. Veronica Popescu, Prof Vincent van Pesch, Prof Bart Van Wijmeersch, Dr Mathieu Vokaer, Dr Barbara Willekens
BELTRIMS
BELTRIMS (Belgian Treatment in Multiple Sclerosis) :
Le but de ce registre est de collecter des données, en situation réelle, sur la tolérance et l’efficacité des médicaments immunomodulateurs, de détecter à court et long terme des effets secondaires inconnus ou sous-évalués et d’étudier les effets éventuels des médicaments concernés en cas de grossesse.
Het doel van het register is het verzamelen van real life data over de tolerantie en de werkzaamheid van de immunomodulerende behandelingen, om zo op korte en lange termijn nog niet ontdekte bijwerkingen in het licht te stellen en de eventuele effecten op zwangerschap te bestuderen.
Agenda
Board meetings 2025:
- February 4
- March 25
- May 20
- October 21
General Assembly:
- June 14